2-((2-Chloro-5-(trifluoromethyl)pyrimidin-4-yl)amino)-N-methylbenzamide → Bis(2-methoxyethyl) (3-methoxy-4-{[4-{[2-(methylcarbamoyl)phenyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}benzyl)phosphonate

HRID 511460Notes

Reaction equation

HRID 511460 reaction equation
Cl[C:2]1[N:7]=[C:6]([NH:8][C:9]2[CH:18]=[CH:17][CH:16]=[CH:15][C:10]=2[C:11]([NH:13][CH3:14])=[O:12])[C:5]([C:19]([F:22])([F:21])[F:20])=[CH:4][N:3]=1.[NH2:23][C:24]1[CH:42]=[CH:41][C:27]([CH2:28][P:29](=[O:40])([O:35][CH2:36][CH2:37][O:38][CH3:39])[O:30][CH2:31][CH2:32][O:33][CH3:34])=[CH:26][C:25]=1[O:43][CH3:44]>>[CH3:44][O:43][C:25]1[CH:26]=[C:27]([CH:41]=[CH:42][C:24]=1[NH:23][C:2]1[N:7]=[C:6]([NH:8][C:9]2[CH:18]=[CH:17][CH:16]=[CH:15][C:10]=2[C:11](=[O:12])[NH:13][CH3:14])[C:5]([C:19]([F:22])([F:21])[F:20])=[CH:4][N:3]=1)[CH2:28][P:29](=[O:40])([O:35][CH2:36][CH2:37][O:38][CH3:39])[O:30][CH2:31][CH2:32][O:33][CH3:34]

Participants

3

Procedure

The title compound was prepared according to Example 102 using 2-{[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino}-N-methylbenzamide (Compound 104A, 50.0 mg, 0.15 mmol) and bis(2-methoxyethyl) (4-amino-3-methoxybenzyl)phosphonate (Compound 217C, 55.4 mg, 0.17 mmol). 58.1 mg (61%) of the desired product obtained after purification. 1H NMR (400 MHz, MeOD) δ ppm 8.24-8.35 (m, 2 H), 7.95 (d, J=8.08 Hz, 1 H), 7.62 (dd, J=7.83, 1.52 Hz, 1 H), 7.46 (ddd, J=8.53, 7.39, 1.52 Hz, 1 H), 7.16 (td, J=7.58, 1.01 Hz, 1 H), 6.96 (t, J=2.02 Hz, 1 H), 6.72-6.80 (m, 1 H), 4.05-4.16 (m, 4 H), 3.87 (s, 3 H), 3.50-3.57 (m, 4 H), 3.33 (s, 6 H), 3.20-3.29 (m, 2 H), 2.89 (s, 3 H). MS (ES+): m/z 628.16/629.20 (100/98) [MH+]. HPLC: tR=1.39 min (Micromass TOF: polar—3 min).

Workup

  1. customThe title compound was prepared

Sources & evidence

ORD record
ord-5cadcc95eb184f80bebfdadac96d053e
Source dataset
uspto-grants-2015_08
Patent number
US09096624B2

Reaction notes

Loading…